Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Domain leads aTyr Pharma's $23mm Series C round

Executive Summary

Domain Associates has led aTyr Pharma Inc.'s $23mm oversubscribed Series C venture round and will contribute one board member. It joins current shareholders Alta Partners, Cardinal Partners, and Polaris Ventures. The company will use the proceeds to continue developing its preclinical pipeline and move physiocrine drug candidates--which have potential to treat patients with blood, immune, and metabolic disorders--into clinical studies. ATyr Pharma has raised $46mm to date.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies